https://www.selleckchem.com/pr....oducts/bromodeoxyuri
The vulnerable time window may be within late gestation and the first year of life. Further study is required to confirm the vulnerable time period of PM on AR. Our study provides evidence that both prenatal and postnatal exposures to PM2.5 are associated with later development of AR. The vulnerable time window may be within late gestation and the first year of life. Further study is required to confirm the vulnerable time period of PM2.5 on AR. The objectives were to compare clinical pharmacist interventions between two